COMMUNIQUÉS West-GlobeNewswire

-
Analogic Corporation to Webcast Annual Stockholders’ Meeting
21/11/2017 - 19:30 -
Bavarian Nordic Announces Exercise of Clinical Option by the US Government under Contract for Freeze-dried IMVAMUNE Smallpox Vaccine
21/11/2017 - 19:06 -
SuperSonic Imagine to Introduce Next-Generation Aixplorer® Ultimate Ultrasound Platform at RSNA 2017
21/11/2017 - 19:00 -
Invuity Appoints Scott Flora to Board of Directors
21/11/2017 - 18:20 -
Abba Medix Grow Facility Improvements and MFT Advances
21/11/2017 - 18:16 -
Ogilvy CommonHealth Worldwide Co-Publishes Primary Research Exploring In-Office Communication
21/11/2017 - 18:15 -
Reporting of transactions made by persons discharging managerial responsibilities in Orphazyme A/S
21/11/2017 - 17:31 -
Genmab Announces Submission of Supplemental Biologics License Application to FDA for Daratumumab in Front Line Multiple Myeloma
21/11/2017 - 17:12 -
Richardson Healthcare Announces New Preferred Replacement Parts Program and CT Service Training at RSNA 2017
21/11/2017 - 17:00 -
Oshkosh Physician Attends National Physicians Council for Healthcare Policy Meeting in Washington, D.C.
21/11/2017 - 15:55 -
RESULTS FROM THE PHASE III HERCULES STUDY OF CAPLACIZUMAB FOR THE TREATMENT OF ACQUIRED TTP SELECTED FOR PRESENTATION IN THE LATE-BREAKING ABSTRACTS SESSION AT THE 2017 ASH ANNUAL MEETING
21/11/2017 - 15:41 -
Data from Phase III ALCYONE Study of Daratumumab Accepted for Oral Presentation at Annual Meeting of the American Society of Hematology
21/11/2017 - 15:34 -
Biothera Pharmaceuticals to Present at the 29th Annual Piper Jaffray Healthcare Conference
21/11/2017 - 15:23 -
Oxford Immunotec to Present at the 29th Annual Piper Jaffray Healthcare Conference
21/11/2017 - 15:15 -
NSS Labs Selected as a 2017 Red Herring Top 100 Global Winner
21/11/2017 - 15:00 -
Zynerba Pharmaceuticals Announces Poster Presentation at the 2017 Annual Meeting of the American Epilepsy Society (AES)
21/11/2017 - 15:00 -
Axim Biotechnologies Announces Phase IIa Trial Results Validating its Proprietary Cannabinoid Delivery Method for Treatment of Irritable Bowel Syndrome (IBS)
21/11/2017 - 15:00 -
Nextech Reports Key Wins, Corporate Expansions
21/11/2017 - 14:50 -
CV Sciences, Inc. Announces its Silver Sponsorship of SOHO Expo in Orlando, FL - December 1-3, 2017
21/11/2017 - 14:45
Pages